GeneFerm Biotechnology Co Ltd (1796) — Working Capital to Net Assets Ratio
GeneFerm Biotechnology Co Ltd (1796) has a Working Capital to Net Assets ratio of 51.3% as of June 2025. Working capital of NT$407.33 Million (current assets of NT$541.91 Million minus current liabilities of NT$134.58 Million) is measured against net assets of NT$794.03 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See GeneFerm Biotechnology Co Ltd balance sheet independence to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
GeneFerm Biotechnology Co Ltd Working Capital to Net Assets (2017–2024)
This chart shows how GeneFerm Biotechnology Co Ltd's Working Capital to Net Assets ratio has evolved across 8 annual periods from 2017 to 2024. As of June 2025, the ratio stands at 51.3%, reflecting working capital of NT$407.33 Million against net assets of NT$794.03 Million TWD. Check GeneFerm Biotechnology Co Ltd tangible book value ratio to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for GeneFerm Biotechnology Co Ltd (2017–2024)
The table below presents the year-by-year Working Capital to Net Assets ratio for GeneFerm Biotechnology Co Ltd from 2017 to 2024, covering 8 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see GeneFerm Biotechnology Co Ltd market cap and net worth.
| Year | WC/NA Ratio | Working Capital (TWD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 35.2% | NT$277.71 Million | NT$788.18 Million | NT$411.97 Million | NT$134.26 Million | ▲ +12.0 pp |
| 2023 | 23.2% | NT$207.27 Million | NT$892.84 Million | NT$397.13 Million | NT$189.86 Million | ▲ +7.0 pp |
| 2022 | 16.2% | NT$134.32 Million | NT$830.77 Million | NT$373.54 Million | NT$239.22 Million | ▼ -28.5 pp |
| 2021 | 44.7% | NT$334.00 Million | NT$747.66 Million | NT$765.18 Million | NT$431.18 Million | ▼ -61.3 pp |
| 2020 | 105.9% | NT$419.73 Million | NT$396.19 Million | NT$535.58 Million | NT$115.85 Million | ▲ +108.5 pp |
| 2019 | -2.5% | NT$-24.31 Million | NT$954.50 Million | NT$21.69 Million | NT$46.00 Million | ▼ -49.4 pp |
| 2018 | 46.8% | NT$195.13 Million | NT$416.51 Million | NT$283.31 Million | NT$88.17 Million | ▲ +18.1 pp |
| 2017 | 28.8% | NT$90.62 Million | NT$314.95 Million | NT$236.26 Million | NT$145.63 Million | — |